3D Ultrasound-Guided Epidural for Labor Pain in Obese Pregnant Women

Recruiting in Palo Alto (17 mi)

Overseen byRovnat Babazade, MD

Age: 18 - 65

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: The University of Texas Medical Branch, Galveston

No Placebo Group

Trial Summary

What is the purpose of this trial?

This study will be a randomized control study, with the objective to evaluate epidural analgesia success rates between the two methods (Blind Approach versus Accuro Device).

Research Team

Rovnat Babazade, MD

Principal Investigator

The University of Texas Medical Branch

Eligibility Criteria

This trial is for pregnant individuals with a BMI of 40 or higher who are at term and want an epidural for pain relief during vaginal delivery. They should be in good to moderate health (ASA class I-III). Those with spinal deformities, allergies to ultrasound gel or local anesthetics, contraindications for epidurals, or unable to understand the consent cannot participate.

Inclusion Criteria

I plan to use epidural pain relief for my vaginal delivery.

Term pregnancy

My overall health is good to moderately impaired.

See 1 more

Exclusion Criteria

I have a known spinal deformity.

Allergies to ultrasound gel

Allergies to local anesthetics

See 3 more

Treatment Details

Interventions

Palpation (Procedure)
Rivanna Accuro 3D Ultrasound Device (Ultrasound-guided Epidural Analgesia)

Trial OverviewThe study compares two methods of guiding epidural analgesia: the traditional 'Blind Approach' versus using the Rivanna Accuro 3D Ultrasound Device. Participants will be randomly assigned to one of these two groups to see which method has higher success rates.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: Rivanna Accuro 3D Ultrasound DeviceExperimental Treatment1 Intervention

The treatment group (Group 1: Ultrasound and Epidural) will receive epidural analgesia using ultrasound pre-procedural scan with the ACCURO device.

Group II: PalpationActive Control1 Intervention

The control group (Group 2: Epidural) will receive the 'Blind/standard approach', which is the current standard of care using palpation in administering labor epidural analgesia. Additionally, an anesthesiologist will scan patient's back with Accuro device in turn off mode.